603193 fundamentals
An in-depth look to RUNBEN BIOTECHNOLOGY CO LTD operating, investing, and financing activities
603193 free cash flow for Q1 25 is -23.88 M CNY. For 2024, 603193 free cash flow was 224.05 M CNY and operating cash flow was 298.27 M CNY.
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−1.40 B
−700.00 M
0.00
700.00 M
1.40 B
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q3 '22
Sep 2022
Q4 '22
Dec 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q4 '23
Dec 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
Q4 '24
Dec 2024
Q1 '25
Mar 2025
TTM
Cash from operating activitiesYoY growth
161.33 M
—
62.67 M
—
66.64 M
—
−28.17 M
+15.64%
188.81 M
+17.03%
40.02 M
−36.14%
97.62 M
+46.48%
−12.61 M
+55.24%
313.84 M
Cash from investing activitiesYoY growth
−85.04 M
—
−11.45 M
—
−1.22 B
—
−150.54 M
−77,088.21%
39.74 M
—
−169.41 M
−1,379.88%
−57.75 M
+95.26%
−31.23 M
+79.26%
−218.65 M
Cash from financing activitiesYoY growth
−616.82 K
—
−2.58 M
—
976.97 M
—
−379.77 K
+59.12%
−74.11 M
−11,915.20%
−379.77 K
+85.27%
−62.68 M
−106.42%
−379.77 K
0.00%
−137.56 M
Free cash flowYoY growth
—
—
64.12 M
—
−30.14 M
+24.30%
182.58 M
—
2.93 M
—
68.68 M
+7.12%
−23.88 M
+20.77%
230.31 M